A paracentese é capaz de alterar a função pulmonar de pacientes cirróticos com ascite?
DOI:
https://doi.org/10.62827/fb.v25i1.g055Palavras-chave:
cirrose Hepática; paracentese; espirometria; capacidade pulmonar total.Resumo
Introdução: Sabe-se que a ascite se destaca como origem de limitações nutricionais, físicas e funcionais do paciente cirrótico. O reflexo negativo da ascite na alteração da pressão intra-abdominal e intratorácica fundamenta a importância da investigação da função pulmonar desses pacientes nos momentos pré e após a paracentese. Objetivo: Comparar a função pulmonar de pacientes cirróticos com ascite, antes e após a paracentese. Métodos: Estudo observacional com nove pacientes cirróticos realizaram paracentese no ambulatório de hepatologia do Hospital Universitário Polydoro Ernani de São Thiago, da Universidade Federal de Santa Catarina. Os pacientes foram submetidos à avaliação da capacidade de exercício por meio do teste de caminhada de 6 minutos (TC6). A avaliação antropométrica e da função pulmonar, foi realizada pré e pós paracentese. Para análise estatística foi realizado o teste de Shapiro-Wilk para avaliação da distribuição dos dados e teste de Wilcoxon para comparação da função pulmonar. Resultados: Não houve diferença estatística na função pulmonar pré e pós a paracentese e na distância percorrida no TC6 comparado aos indivíduos saudáveis. Conclusões: A paracentese isoladamente parece não alterar a função pulmonar. Sendo assim, importante investigar os efeitos das terapias de reexpansão pulmonares associadas ao tratamento clínico nessa população.
Referências
Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol. 2021 Jul;56(7):593-619. doi: 10.1007/s00535-021-01788-x. Epub 2021 Jul 7. PMID: 34231046; PMCID: PMC8280040.
Rossi D, D'Avila AF, Galant LH, Marroni CA. Exercise in the physical rehabilitation of cirrotics: a randomized pilot study. Arq Gastroenterol. 2022 Jul-Sep;59(3):408-413. doi: 10.1590/S0004-2803.202203000-73. PMID: 36102440.
Younossi ZM, Stepanova M, Lawitz EJ, Reddy KR, Wai-Sun Wong V, Mangia A, Muir AJ, Jacobson I, Djedjos CS, Gaggar A, Myers RP, Younossi I, Nader F, Racila A. Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life. Am J Gastroenterol. 2019 Oct;114(10):1636-1641. doi: 10.14309/ajg.0000000000000375. PMID: 31464743.
Harvey, J.J., Prentice, R. and George, J. (2023), Diagnostic and therapeutic abdominal paracentesis. Med J Aust, 218: 18-21. https://doi.org/10.5694/mja2.51795
Macken L, Corrigan M, Prentic W on behalf of the British Association for the Study of the Liver/British Society of Gastroenterology (BASL/BSG) End of Life Special Interest Group, et al Palliative long-term abdominal drains for the management of refractory ascites due to cirrhosis: a consensus document Frontline Gastroenterology 2022;13:e116-e125.
Wittmer VI, Lima RT, Maia MC, Duarte H, Paro FM. Respiratory and symptomatic impact of ascites relief by paracentesis in patients with hepatic cirrhosis. Arq Gastroenterol. 2020 Jan; 57(1):64–8. https://doi.org/10.1590/S0004-2803.202000000-11
Drew L. Liver cirrhosis: scar wars. Nature. 2018 Dec; 564(7736):S73. doi: 10.1038/d41586-018-07759-2. PMID: 30568207.
D'Amico G, Morabito A, D'Amico M, Pasta L, Malizia G, Rebora P, Valsecchi MG. Clinical states of cirrhosis and competing risks. J Hepatol. 2018 Mar;68(3):563-576. doi: 10.1016/j.jhep.2017.10.020. Epub 2017 Oct 27. PMID: 29111320.
Tokumoto, Y., & Hiasa, Y. Nihon Shokakibyo Gakkai zassh i= The Japanese journal of gastro-enterology. 2021,118(1),30–40. doi: 10.11405/nisshoshi.118.30
Nasser I, Miranda H, Perez RM, Cabiddu R, Malosa L, Dias I, Brown A, Reis MS. Limited cardiopulmonary capacity in patients with liver cirrhosis when compared to healthy subjects. Rev Assoc Med Bras (1992). 2021 Jan;67(1):94-100. doi: 10.1590/1806-9282.67.01.20200449. PMID: 34161483.
Zhao R, Lu J, Shi Y, Zhao H, Xu K, Sheng J. Current management of refractory ascites in patients with cirrhosis. J Int Med Res. 2018 Mar;46(3):1138-1145. doi: 10.1177/0300060517735231. Epub 2017 Dec 6. PMID: 29210304; PMCID: PMC5972247.
Kok, Beverley K, Reid W, Thomas F, Robert JB, Kelly WB, Jan K, Navdeep T, Puneeta T. Health-Related Quality of Life: A Rapid Predictor of Hospitalization in Patients With Cirrhosis. The American Journal of Gastroenterology 115(4):p 575-583, April 2020. | DOI: 10.14309/ajg.0000000000000545
Keating SE, Hackett DA, George J, Johnson NA. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012 Jul;57(1):157-66. doi: 10.1016/j.jhep.2012.02.023. Epub 2012 Mar 10. PMID: 22414768.
Georgakopoulou VE, Asimakopoulou S, Cholongitas E. Pulmonary function testing in patients with liver cirrhosis (Review). Med Int (Lond). 2023 Jul 6;3(4):36. doi: 10.3892/mi.2023.96. PMID: 37533800; PMCID: PMC10391595.
Mah JM, Dewit Y, Groome P, Djerboua M, Booth CM, Flemming JA. Early hospital readmission and survival in patients with cirrhosis: A population-based study. Can Liver J. 2019 Aug 27;2(3):109-120. doi: 10.3138/canlivj.2018-0025. PMID: 35990219; PMCID: PMC9202749.
Moiséli MLC, Valesca DA, Bruna CA. Avaliação da ingestão de sódio, calorias e desnutrição em pacientes com cirrose hepática e ascite refratária. Universidade Federal do Rio Grande do Sul, Departamento de Nutrição. 2021
Wang Z, Li S, Wang K, Zhang M, Wu J, Liu D, Liang K. Association of sarcopenia with liver fibrosis and steatohepatitis in non-alcoholic fatty liver disease: protocol for a systematic review and meta-analysis. BMJ Open. 2023 Feb 3;13(2):e066181. doi: 10.1136/bmjopen-2022-066181. PMID: 36737085; PMCID: PMC9900053.
Knudsen AW, Krag A, Nordgaard-Lassen I, Frandsen E, Tofteng F, Mortensen C, Becker U. Effect of paracentesis on metabolic activity in patients with advanced cirrhosis and ascites. Scand J Gastroenterol. 2016;51(5):601-9. doi: 10.3109/00365521.2015.1124282. Epub 2015 Dec 16. PMID: 26673350.
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. Corrigendum to "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis" [J Hepatol 69 (2018) 406-460]. J Hepatol. 2018 Nov;69(5):1207. doi: 10.1016/j.jhep.2018.08.009. Epub 2018 Aug 29. Erratum for: J Hepatol. 2018 Aug;69(2):406-460. PMID: 30172388.
Wittmer VL, Lima RT, Maia MC, Duarte H, Paro FM. Respiratory and symptomatic impact of ascites relief by paracentesis in patients with hepatic cirrhosis. Arq Gastroenterol. 2020 Jan-Mar;57(1):64-68. doi: 10.1590/S0004-2803.202000000-11. PMID: 32294737.
Roque L, Sankarankutty AK, Silva OC Jr, Mente ED. Evaluation of Lung Function in Liver Transplant Candidates. Transplant Proc. 2018 Apr;50(3):762-765. doi: 10.1016/j.transproceed.2018.02.023. PMID: 29661432.
Aithal GP, Palaniyappan N, China L, Härmälä S, Macken L, Ryan JM, Wilkes EA, Moore K, Leithead JA, Hayes PC, O'Brien AJ, Verma S. Guidelines on the management of ascites in cirrhosis. Gut. 2021 Jan;70(1):9-29. doi: 10.1136/gutjnl-2020-321790. Epub 2020 Oct 16. PMID: 33067334; PMCID: PMC7788190.
La Mura V, Salerno F. Therapy of the refractory ascites: Total paracentesis vs. TIPS. Gastroenterol Hepatol. 2016 Aug-Sep;39(7):477-80. doi: 10.1016/j.gastrohep.2015.07.011. Epub 2015 Nov 18. PMID: 26596208.
Biggins SW, Angeli P, Garcia-Tsao G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021; 74: 1014-1048.
Runyon BA. Diagnostic and therapeutic abdominal paracentesis. UpToDate [Internet]. 2019 Nov; [acesso em 2023 setembro 11 ]. Disponível em: Diagnostic and therapeutic abdominal paracentesis - UpToDate
Rohana N. Haththotuwa, Chandrika N. Wijeyaratne, Upul Senarath, Chapter 1 - Worldwide epidemic of obesity, Editor(s): Tahir A. Mahmood, Sabaratnam Arulkumaran, Frank A. Chervenak, Obesity and Obstetrics (Second Edition), Elsevier, 2020; 3-8, ISBN 9780128179215. https://doi.org/10.1016/B978-0-12-817921-5.00001-1.
Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Oct;158(4):1185-9. doi: 10.1164/ajrccm.158.4.9802091. PMID: 9769280.
Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, Hallstrand TS, Hankinson JL, Kaminsky DA, MacIntyre NR, McCormack MC, Rosenfeld M, Stanojevic S, Weiner DJ; ATS Committee on Proficiency Standards for Pulmonary Function Laboratories. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2017 Dec 1;196(11):1463-1472. doi: 10.1164/rccm.201710-1981ST. PMID: 29192835.
Orme M., Pina I, Ndagire P., Latimer L., Zatloukal J., Kirenga B., Singh S.J, Katagira W. American Thoracic Society: Assessing The Pathophysiology And Psychology Of Patients For Rehabilitation., 2022 May 1; A5214-A5214.
Britto RR, Probst VS, de Andrade AF, Samora GA, Hernandes NA, Marinho PE, Karsten M, Pitta F, Parreira VF. Reference equations for the six-minute walk distance based on a Brazilian multicenter study. Braz J Phys Ther. 2013 Nov-Dec;17(6):556-63. doi: 10.1590/S1413-35552012005000122. Epub 2013 Nov 14. PMID: 24271092; PMCID: PMC4207140.
Benz F, Mohr R, Tacke F, Roderburg C. Pulmonary Complications in Patients with Liver Cirrhosis. J Transl Int Med. 2020 Sep 25;8(3):150-158. doi: 10.2478/jtim-2020-0024. PMID: 33062591; PMCID: PMC7534492.
Gonçalez, JC, Francisco S, Conceição, MA, Peruzzolo C, Mello L, Lúcio N, Paulin, E. Diaphragmatic mobility of cirrhotic patients with ascites after paracentesis. Brazilian Journal of Health Research, 2023 24(4),6–12. doi: 10.47456/rbps.v24i4.36373
Laveneziana P, Albuquerque A, Aliverti A, et al. ERS statement on respiratory muscle testing at rest and during exercise. Eur Respir J 2019; 53: 1801214 [https://doi.org/10.1183/13993003.01214- 2018].
Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, Cooper BG, Culver B, Derom E, Hall GL, Hallstrand TS, Leuppi JD, MacIntyre N, McCormack M, Rosenfeld M, Swenson ER. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022 Jul 13;60(1):2101499. doi: 10.1183/13993003.01499-2021. PMID: 34949706.
Bhandari K, Kapoor D. Fatigue in Cirrhosis. J Clin Exp Hepatol. 2022 Mar-Apr;12(2):617-624. doi: 10.1016/j.jceh.2021.08.028. Epub 2021 Sep 4. PMID: 35535102; PMCID: PMC9077229.
Choo, Yoo Jina; Cho, Chan Woob; Chang, Min Cheolc. Effects of supervised exercise on aerobic capacity and quality of life in patients with chronic liver disease and patients who underwent liver transplantation: a systematic review and meta-analysis. International Journal of Rehabilitation Research 45(1):p 1-11, March 2022. | DOI: 10.1097/MRR.0000000000000502
Van der Lee L, Hill AM, Jacques A, Patman S. Efficacy of Respiratory Physiotherapy Interventions for Intubated and Mechanically Ventilated Adults with Pneumonia: A Systematic Review and Meta-Analysis. Physiother Can. 2021 Winter;73(1):6-18. doi: 10.3138/ptc-2019-0025. PMID: 35106019; PMCID: PMC8774958.
García-Castillo FJ, López-Ropero M, Anciano-Campo P, Arias-Arias A, Revisión sistemática de intervenciones de fisioterapia respiratoria y sus efectos en la función pulmonar en pacientes obesos intervenidos de cirugía bariátrica, Fisioterapia, 2023 45(4):217-234, ISSN 0211-5638, https://doi.org/10.1016/j.ft.2023.01.004.
Lai JC, Dodge JL, Kappus MR, Wong R, Mohamad Y, Segev DL, McAdams-DeMarco M. A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE). Am J Gastroenterol. 2021 Apr;116(4):717-722. doi: 10.14309/ajg.0000000000001113. PMID: 33982941; PMCID: PMC8178511.
Wang, St., Zheng, J., Peng, Hw. et al. Physical activity intervention for non-diabetic patients with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. BMC Gastroenterol 20, 66 (2020). https://doi.org/10.1186/s12876-020-01204-3
Williams, F.R., Milliken, D., Lai, J.C. and Armstrong, M.J. (2021), Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability. Hepatol Commun, 5: 923-937. https://doi.org/10.1002/hep4.1688
West J, Gow PJ, Testro A, Chapman B, Sinclair M. Exercise physiology in cirrhosis and the potential benefits of exercise interventions: A review. J Gastroenterol Hepatol. 2021 Oct;36(10):2687-2705. doi: 10.1111/jgh.15474. Epub 2021 Mar 10. PMID: 33638197.
Chen, H.W., Ferrando, A., White, M.G. et al. Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial. Dig Dis Sci 65, 3350–3359 (2020). https://doi.org/10.1007/s10620-019-06034-2
Publicado
Edição
Seção
Licença
Copyright (c) 2024 Andrielli Inocêncio, Jéssica Canizelli Gonçalez , Davi de Souza Francisco, Mariana Nunes Lúcio, Carolina Luana de Mello, Thais Martins Albanaz da Conceição, Elaine Paulin Ferrazeane (Autor)
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution 4.0 que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
Autores têm autorização para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
